Dr Sheth also spoke about staffing gaps at NMC, action taken against medical colleges for non-compliance, MBBS fee regulation, and the rollout of the National Exit Test (NExT).

Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six months in BCG-Unresponsive patients Company expects ...

An FDA risk review has cleared the way for canine freeze-dried plasma, a shelf-stable product that could expand transfusion options in emergencies. A freeze-dried plasma product for canine patients is ...

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Evkeeza Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...

Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026Initiated global Phase 3 LEVEL-2 ...

Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global Phase 3 LEVEL-2 clinical trial and opened long-term OLE study for patients ...